The Gold Standard of HSA Medical Device Dealer Licensing Services | Qualified Supply and Verifiable Patient Safety

A medical-device importer in Singapore begins wholesaling diagnostic equipment to hospitals. Its sales team assumes the HSA Importer’s Licence already authorises all distribution. But importing, wholesale supply and manufacturing have different dealer permissions, and the particular device may separately need product registration. One green business licence is not proof of every other regulatory step.

The Gold Standard of HSA Medical Device Dealer Licensing Services is a traceable route from the company’s genuine commercial activities through recognised ISO 13485 or GDPMDS quality controls, HSA’s SHARE application, a current annual dealer licence, accurate product records and effective action when devices prove unsafe. It protects patients and legitimate suppliers by separating evidence from permission.

HSA’s June 2026 guidance sets three licence types: Importer, Wholesaler and Manufacturer. Each costs S$1,110 for a new or annual licence, with a ten-working-day indicative processing target. Ordinary dealer licences last twelve months and the 2026 amendment fee is S$168. Product registration, Class A notification and patient safety obligations remain separate.

The medical-device supply chain from dealer class to safety action

The chapter map separates manufacturer, importer and wholesaler activities, QMS evidence, HSA SHARE, fees, renewal, product notification and post-market duties. Each milestone has a distinct outcome.

1. Know whether you manufacture, import or wholesale

A healthcare supplier may describe itself simply as a medical device company while performing several legally distinct functions. The appropriate licence depends on what it actually does with devices, rather than the business name or its sales team’s description.

HSA’s June 2026 licensing guidance distinguishes manufacturer, importer and wholesaler permissions. A service should document each physical activity and device class. A company importing and distributing may need more than one licence; an ACRA profile alone cannot authorise regulated medical-device supply.

Back to licence guide · Next chapter

2. Define an importer’s authority narrowly

Bringing medical devices through Singapore Customs is a commercial import activity. A company should not treat the ability to clear a shipment as permission to sell that consignment through every later distribution channel.

HSA’s Importer’s Licence authorises a firm to import devices into Singapore. Licensed importers require a separate Wholesaler’s Licence for wholesale supply. A Gold Standard application asks who receives the stock next, the site where it is stored and whether the intended recipient will use or resupply the product.

Back to licence guide · Next chapter

3. Define wholesale activity precisely

A wholesaler may supply hospitals, clinics and another distributor, and can export or provide devices as commercial samples. These arrangements differ from a retail sale directly to a final consumer.

HSA states the wholesaler licence covers wholesale supply, including export, supply for re-supply and commercial sampling. It is not required solely for direct end-user retail, though all applicable product and consumer safeguards remain. A licensing portal should not make every small retail business buy an irrelevant licence or imply retail is universally unregulated.

Back to licence guide · Next chapter

4. Recognise manufacturing, packaging and labelling

A business may not fabricate a machine from raw parts, but still perform steps that qualify as regulated manufacturing. Packaging or applying the final device label can be consequential for clinical safe use.

HSA’s Manufacturer’s Licence covers making, fabricating, producing, processing, packaging and labelling devices before supply. A reviewer should ask where these operations occur and which quality processes cover them. The fact that a foreign original equipment manufacturer designed the device does not establish that Singapore-based work falls outside the manufacturing framework.

Back to licence guide · Next chapter

5. Use the manufacturer’s own-product wholesale exception correctly

A manufacturer licensed for certain medical devices may be allowed to supply those products without a separate wholesaler permission. But a wholly unrelated imported range can change the analysis.

HSA says manufacturers need no extra Wholesaler’s Licence to supply devices manufactured under their own Manufacturer’s Licence. The exception should be applied to the genuine product scope, not to everything the company’s commercial division resells. A case system should link product lines to the responsible licence and permitted activity.

Back to licence guide · Next chapter

6. Begin with medical-device risk classification

A simple Class A low-risk device and a Class D high-risk device should not trigger identical quality evidence and product approval checklists. Incorrect risk classification can create serious gaps.

HSA divides regulated devices into Classes A, B, C and D. Dealers should declare which classes their operating system and QMS cover, using the applicable HSA risk classification rules. A Class A-only declaration route cannot automatically support a later Class C product without additional certification and relevant licence changes.

Back to licence guide · Next chapter

7. Separate business licence from product authorisation

An importer might hold a valid licence while its proposed Class C monitor has never been registered in Singapore. A hospital buyer should not interpret the first document as proof of the second.

HSA requires dealer licences for regulated manufacture, import and wholesale, while most Class B, C and D products require separate registration and a listing in the Singapore Medical Device Register. A Gold Standard service displays company permitted, product cleared and shipment legally imported as distinct decisions.

Back to licence guide · Next chapter

8. Handle Class A notification rather than call it no approval

Class A medical devices are exempt from the ordinary product registration process, but this does not mean HSA needs no information about products handled by local suppliers.

HSA requires an appropriate Class A product notification through SHARE for devices that dealers import or manufacture. The low-risk pathway is a defined regulatory simplification, not a way to bypass accurate labelling, dealer licensing, traceability or post-market safety responsibilities.

Back to licence guide · Next chapter

9. Use SHARE instead of an old MEDICS form

Some industry manuals and saved bookmarks still refer to the earlier medical-device electronic portal. Applications filed to an obsolete route can cause unnecessary delay or confusion about status.

HSA launched the Singapore Health Product Access and Regulatory E-System, SHARE, for medical devices in July 2025. The current 2026 page lists dealer applications, amendments, product registrations, Class A notifications and withdrawal. Business representatives use authorised Corppass access, not someone else’s Singpass password.

Back to licence guide · Next chapter

10. Identify the true operating company and sites

A local dealer may have a small registered office but receive and distribute products through another warehouse. It may use an outsourced logistics provider with different storage controls.

The licence’s operating details and QMS should reflect actual sites, outsourced providers and activity scope. A Gold Standard application asks for each relevant address and role rather than assume a UEN proves compliance at every warehouse. Changes later in the year should also follow the prescribed amendment process.

Back to licence guide · Next chapter

11. Establish a quality management system before applying

Medical devices can become unsuitable through mishandling, poor storage, untraceable dispatch or ineffective corrective action. A dealer licence is intended to confirm more than the ability to pay a statutory fee.

HSA requires a suitable Quality Management System for manufacturers, importers and wholesalers. This should support staff responsibilities, receiving checks, storage, supplier control, distribution records, complaints and corrections. A certificate without real implementation does not create dependable patient-safe supply.

Back to licence guide · Next chapter

12. Choose ISO 13485 or GDPMDS for the actual activities

A manufacturer controls design and production processes, while a wholesaler may focus on distribution, inventory condition and traceability. The corresponding regulatory standards are related but distinct.

HSA’s July 2026 QMS guidance requires manufacturers to conform to ISO 13485. Importers and wholesalers can use ISO 13485 or Singapore Standard SS620 Good Distribution Practice for Medical Devices. The actual certificate must cover the declared product categories and sites.

Back to licence guide · Next chapter

13. Use recognised accredited certification evidence

A training-provider certificate or an overseas commercial logo is not necessarily an acceptable accredited quality-system audit for the relevant dealer scope.

For Class B to D activity, HSA allows appropriate ISO 13485, GDPMDS or MDSAP evidence under its rules. Applicable Singapore certification bodies must be accredited by the Singapore Accreditation Council. A full supporting package includes the quality certificate and audit report, with correct scope and validity.

Back to licence guide · Next chapter

14. Allow the Class A-only declaration route where applicable

Smaller dealers handling only low-risk Class A products may qualify for a less demanding declaration route. That does not mean the business has no responsibility for quality or truthful assessment.

HSA accepts specified QMS conformity declarations for Class A-only importer and wholesaler activity and an ISO 13485 declaration for Class A-only manufacturers. The service should check the business genuinely handles only eligible products. A later move into B, C or D devices can require certification, product registration and licence amendment.

Back to licence guide · Next chapter

15. Classify export-only businesses without promising local market access

A trader may import devices solely to re-export them, without offering them to Singapore hospitals. HSA provides prescribed declarations for such transactions, but their terms must be understood.

The dealer application includes a declaration for eligible solely export or re-export activities. A company should identify the actual destinations and supply arrangements. The declaration cannot be treated as clearance for local clinical sales and does not remove separate Customs and controlled-goods requirements.

Back to licence guide · Next chapter

16. Separate each S$1,110 statutory charge

An importing distributor may need both an Importer’s Licence and a Wholesaler’s Licence. Its budget should reflect two government transactions rather than one company-wide fee.

HSA’s March 2026 fee table lists S$1,110 for each new or annual manufacturer, importer and wholesaler licence. A firm needing both import and wholesale permissions should account for both charges, along with any external accredited audit or product evaluation cost.

Back to licence guide · Next chapter

17. Treat ten working days as an assessment target

A prospective supplier may promise a hospital delivery in ten days after submitting a blank application. The published processing time assumes a proper, complete file and does not make approval certain.

HSA lists a ten-working-day dealer licensing turnaround, excluding applicant time spent answering clarification requests. A Gold Standard tracking screen identifies document deficiencies, applicant stop-clock, review resumed, decision and actual licence issuance. Payment or a received reference alone is not authorisation to deal.

Back to licence guide · Next chapter

18. Keep amendments distinct from full annual renewal

A dealer can remain licensed while changing warehouse, activity scope or quality certification. Waiting until renewal to report a material change can invalidate current declared particulars.

HSA’s 2026 amendment guide lists site, outsourced service, certification, quality-system type and risk class changes. The statutory amendment fee is S$168 with ten working days of indicative review. A service should identify exactly what changed, not file a new product registration for a pure warehouse change.

Back to licence guide · Next chapter

19. Update an expiring QMS certificate separately

A dealer’s annual licence and supporting quality certificate can have different expiry dates. Renewing one does not automatically renew the other.

HSA directs licensees to update QMS certificate validity and certified scope using the relevant licence amendment route. A quality dashboard should maintain certificate issuer, audit report, covered sites and dates, and flag gaps before they affect legal operation. An outdated certificate is not made current by scanning it again.

Back to licence guide · Next chapter

20. Track the dealer licence’s twelve-month validity

Some firms confuse a device’s product registration duration with the business licence and assume both continue until the next product review.

HSA says dealer licences are valid for twelve months after approval. Once a licence expires without timely renewal, the dealer must apply for a new licence before resuming that regulated activity. A good account clearly identifies the business type, actual licence number, issued date and expiry, not a generic perpetual approval badge.

Back to licence guide · Next chapter

21. Allow manual renewal from sixty days before expiry

A dealer without a working GIRO arrangement needs enough time to verify company details and settle the fee before the existing licence lapses.

HSA permits manual renewal from sixty days before expiry, with recognised electronic payment methods. The licensee should update changed particulars first. An unpaid renewal checkout or an application saved as a draft must never be presented as an issued continuation.

Back to licence guide · Next chapter

22. Explain the GIRO auto-renewal timing

A company may authorise GIRO shortly before its licence ends and assume a debit will succeed immediately. Bank-mandate activation and HSA’s renewal schedule have their own lead times.

HSA advises setting up the arrangement at least sixty days ahead, with auto-renewal deduction activated around thirty days before expiry. If GIRO is not ready, a manual renewal should be completed. The service should verify actual fee settlement rather than merely show GIRO selected.

Back to licence guide · Next chapter

23. Do not treat an expired licence as active pending review

A distributor might submit a new application after expiry but continue shipments because HSA previously licensed the same company.

The HSA renewal guidance says an expired dealer licence is invalid and requires a new licence before continuing regulated dealing. A Gold Standard portal should indicate authorised, approaching expiry, expired, new application under review and renewed as separate states.

Back to licence guide · Next chapter

24. Protect product condition during receiving and storage

A clinical device can be damaged or degraded by mishandling even when its original manufacturing quality was high. A licensed supply chain needs suitable receiving and warehouse controls.

The GDPMDS and ISO 13485 quality frameworks require procedures appropriate to the operation. A competent dealer should document receipt, suitable storage, quarantine of suspect goods and controlled release. Regulatory review should tie procedures to actual facilities and staff rather than accept generic manuals copied from another company.

Back to licence guide · Next chapter

25. Record lots, customers and onward supply accurately

An equipment defect discovered six months later must be traced to affected hospitals, clinics, distributors or patients where applicable. Without reliable distribution data, recall communications can miss the people most at risk.

HSA imposes recordkeeping and post-market duties on medical device dealers. The business should be able to identify products by model and relevant lot or serial, along with recipients and dates. A Gold Standard case can reconcile recall scope to real dispatches rather than send unverified notices to every contact in a mailing list.

Back to licence guide · Next chapter

26. Handle complaints and adverse events as distinct cases

A damaged carton and a serious clinical malfunction may both enter through customer support, but their risks and reporting duties are not identical.

HSA’s regulatory overview requires dealers to handle complaints and report qualifying adverse events. The operator should identify the device, patient or user risk, findings and actual notification route. A complaint record is not automatically a regulatory adverse-event report, and a rejected allegation must be assessed on evidence.

Back to licence guide · Next chapter

27. Use field safety corrective action when necessary

A device producer may discover a safety problem only after units have been supplied. Corrective actions can include more than retrieving every unit; updates, relabelling or new instructions may sometimes be relevant.

HSA’s 2026 FSCA guidance explains risk-reduction actions and reporting via OSCAR. A dealer should document affected models, recipients, required action, completion and remaining risks. Merely sending a notice does not prove every hospital acted on it.

Back to licence guide · Next chapter

28. Differentiate product technical changes from dealer amendments

A manufacturing site moving address changes company licence particulars. A medical device’s software, intended use or safety design changing can instead trigger a product-registration Change Notification.

HSA’s device Change Notification rules apply to specified B, C and D changes. The service should choose the correct pathway and where needed coordinate both. One company’s wholesale licence amendment does not automatically authorise a materially modified registered device.

Back to licence guide · Next chapter

29. Recognise controlled drug-of-abuse test kits

Certain testing products involve controls in addition to their ordinary medical-device status. A hospital purchaser should not infer every such product is cleared merely because its packaging resembles a medical diagnostic kit.

HSA says drug-of-abuse test kit dealing may require a separate controlled drugs licence under the Misuse of Drugs Act. The company must identify such products early and use the correct regulator routes. Medical device licensing should never be marketed as universal authority for every controlled diagnostic product.

Back to licence guide · Next chapter

30. Worked example: importing then wholesaling monitors

Fictional Orchard Diagnostics imports approved monitoring equipment from a foreign manufacturer and holds a valid Importer’s Licence. Its sales team plans to distribute cartons to another company for resale. They regard the importer certificate as enough.

The wholesaling activity requires checking the corresponding Wholesaler’s Licence, suitable GDPMDS or ISO 13485 evidence and device product authorisation. If both dealer licences are needed, the current statutory annual charges total S$2,220, excluding audit and product costs. The company should verify actual issuance before the shipment is supplied onward.

Back to licence guide · Next chapter

31. Worked example: a Class A-only enterprise expands

Fictional Willow MedTech sells a low-risk notified Class A product and uses the prescribed quality declaration arrangement. It decides to import a new Class C monitoring device but assumes its Class A-only certificate and saved SHARE profile are still sufficient.

The change requires updated risk and dealer scope, appropriate accredited QMS documentation and separate product registration before lawful relevant import or supply. A competent service identifies each gate and applicable fees. It does not approve the expansion simply because the company’s original UEN and warehouse remain unchanged.

Back to licence guide · Next chapter

32. Worked example: a distributor relocates its store

Fictional Seaside Clinical Supply has an active wholesaler licence and GDPMDS accreditation for an approved warehouse. It moves stock to a larger facility without updating HSA and continues using the old address on client invoices.

A Gold Standard change process identifies the new site, QMS controls, updated certification scope where required and a valid SHARE dealer amendment. The company then reconciles inventory and customer dispatch records. A change in physical premises cannot be hidden as a routine marketing update when regulatory storage and distribution are affected.

Back to licence guide · Next chapter

33. Judge licensing by safe supply, not certificate counts

A regulator might approve many dealer applications while quality systems lapse, unregistered products enter commerce or hospitals cannot locate devices named in a safety notice. That would defeat the public purpose of licensing.

The Gold Standard is correct dealer class, valid QMS, truthful device risk and product registration, timely annual renewal, reliable supply traceability and completed safety action. Its outcome is a device reaching a legitimate user in controlled condition, with clear responsibility if the product later proves unsafe.

Back to licence guide

What each HSA dealer licence allows

Statutory charges and review windows in 2026

Frequently asked questions for Singapore device suppliers

• Does an HSA Importer’s Licence permit all wholesale sales? No. A Wholesaler’s Licence is generally required for wholesale supply.
• Does an HSA manufacturer need wholesale approval for devices made under its manufacturing licence? HSA generally provides an exception for those own-manufactured devices.
• Is a Class A device entirely exempt from regulation? No. Product notification, dealer and safety duties remain.
• Can a Class A-only dealer make a QMS declaration? Where HSA’s Class A-only conditions permit it, yes.
• Are dealer licences valid for five years? No. The ordinary term is twelve months.
• Can a dealer continue supplying after licence expiry with a pending new application? Not until properly licensed.
• Does product registration remove the duty to report recalls or defects? No. Post-market obligations remain.

A verifiable dealer-licensing and patient safety audit

• Is the real business activity classified as manufacturer, importer or wholesaler correctly?
• Do the specific risk classes and products align with current licence scope?
• Are accredited QMS certificate, audit and sites appropriate to the operation?
• Is Class A notification separated from B–D registration and dealer licensing?
• Are annual S$1,110 fees distinguished per business permission and from product fees?
• Can the applicant see SHARE review status, stop-clock and issuance?
• Are annual renewal and GIRO payment dates accurately tracked?
• Do real site and QMS changes trigger the right S$168 amendment?
• Can affected model and distribution records be used for timely recall and FSCA action?
• Does performance demonstrate safe traced supply rather than simply licences sold?

HSA official guidance and connected eduKate articles

• HSA: Medical Device Dealer Licensing applications
• HSA: Quality Management Systems ISO 13485 and GDPMDS, July 2026
• HSA: 2026 dealer licence fee, amendment and time
• HSA: Dealer renewal and cancellation
• HSA: Change dealer site, QMS or scope
• HSA: Medical devices regulatory framework
• HSA: Device registration and Class A notification
• HSA: SHARE medical device government portal
• HSA: Field Safety Corrective Actions
• HSA: Product Change Notifications
• eduKate: HSA Medical Device Product Registration
• eduKate: Medical Device Distribution Companies
• eduKate: HCSA Healthcare Licensing

Featured editorial photograph: a laboratory worker in a white coat; the image does not identify an HSA-licensed medical device dealer or certified warehouse. Part of The Gold Standard | eduKate Singapore and the Sectors and Services Directory. Actual HSA licence terms, product listings and safety requirements govern individual supply decisions.